| TB patients from the pilot sites (Aragatsotn, Kotayk, Shirak provinces) | P-value | ||||||||
Comparison group 2011 and 2013 N = 163 | FBC 2012 | FBC 2012 participants vs. comparison group | FBC 2012 participants vs. refusals | |||||||
Participants N = 55 | Refusals N = 14 | Total N = 69 | ||||||||
General characteristics % (n) | ||||||||||
Age mean (SD)a | 47.4 | (9.6) | 49.3 | (12.8) | 39.8 | (15.9) | 47.4 | (13.9) | 0.25 | 0.02b |
Gender: males | 74.2 | (121) | 61.8 | (34) | 78.6 | (11) | 66.7 | (46) | 0.08c | 0.24 |
Extra-pulmonary TB | 27.6 | (45) | 21.8 | (12) | 21.4 | (3) | 21.7 | (15) | 0.40 | 0.97 |
Retreated cases | 24.9 | (39) | 25.5 | (14) | 14.3 | (2) | 23.2 | (16) | 0.93 | 0.38 |
Smear-positive | 25.2 | (41) | 25.5 | (14) | 35.7 | (5) | 27.5 | (19) | 1.0 | 0.45 |
Treatment outcomes % (n) | ||||||||||
‘Success’ | 90.2 | (147) | 96.4 | (53) | 92.9 | (13) | 95.7 | (66) | 0.08c | 0.35 |
‘Lost-to-follow-up’ | 4.9 | (8) | 0 | (0) | 7.1 | (1) | 1.4 | (1) | 0.07c | 0.13 |
‘Failure’ | 3.7 | (6) | 3.6 | (2) | 0 | (0) | 2.9 | (2) | 0.85 | 0.48 |
‘Death’ | 1.2 | (2) | 0 | (0) | 0 | (0) | 0 | (0) | 0.46 | 1.00 |